Suchergebnisse - "Li, Yilin"

PubPharm (8)

1

Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer

enthalten in: Human cell | 2021

von Chen, Y. | Yuan, J. | Li, Y. | +5

2

Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Li, Y. | Zhang, X. | Liu, D. | +9

3

Value of serum human epithelial growth factor receptor 2 extracellular domain and circulating tumor cells in evaluating therapeutic response in advanced gastric cancer

enthalten in: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery | 2017

von Li, Y. | Peng, Z. | Zhang, X. | +2

4

The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer

enthalten in: Cancer letters | 2016

von Wang, Q. | Zhang, X. | Shen, E. | +9

5

Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer

enthalten in: British journal of cancer | 2016

von Li, Y. | Gong, J. | Zhang, Q. | +5

6

Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma

enthalten in: BMC cancer | 2015

von Xu, Y. | Peng, Z. | Li, Z. | +5

7

Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer

enthalten in: Oncotarget | 2014

von Li, Y. | Zhang, X. | Ge, S. | +8

8

Prognostic significance of MET amplification and expression in gastric cancer : a systematic review with meta-analysis

enthalten in: PloS one | 2014

von Peng, Z. | Zhu, Y. | Wang, Q. | +5

1
[1]